{
    "code": "06023000",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06023000",
    "time": "2019-08-09 03:07:03",
    "許可證字號": "衛署醫器輸字第023000號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/10\/27",
    "發證日期": "100\/10\/27",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00602300000",
    "中文品名": "海派栓塞微球體",
    "英文品名": "HepaSphere Embolization Microspheres",
    "效能": "用於血管栓塞術，使用時可以選擇是否注入Doxorubcin-HCl，而為下列的處置做治療或術前準備１、肝細胞腫瘤栓塞術；２、轉移性肝癌栓塞術。適應症變更為：詳如中文仿單核定本(原105年5月18日核定之仿單標籤核定本予以作廢)。",
    "醫器規格": "V325HS(Size：53-106μm, 25mg\/vial),以下空白。增加規格：V225HS。原101年11月8日標籤仿單核定本回收作廢。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "E心臟血管用裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "1103401100  健喬信元醫藥生技股份有限公司",
        "申請商地址": "新竹縣湖口鄉光復北路21巷4號",
        "主製造廠": "",
        "製造廠名稱": "MFR0148000  BIOSPHERE MEDICAL S.A.",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060230000001-108-07-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06023000&Seq=005&Type=9"
        },
        {
            "title": "060230000001-108-07-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06023000&Seq=002&Type=8"
        }
    ]
}